Kaufman J, Leikin J, Kendzierski D, Polin K
Department of Pediatrics, College of Medicine, University of Illinois, Chicago.
Pediatr Emerg Care. 1990 Jun;6(2):118-21. doi: 10.1097/00006565-199006000-00013.
We report the use of digoxin immune Fab in a seven-day-old male neonate for treatment of digoxin poisoning. The patient was being treated with digoxin for paroxysmal supraventricular tachycardia (PSVT). The prescription was written for digoxin elixir (50 micrograms/ml), 10 micrograms bid; however, it was dispensed as 100 micrograms bid. The patient had received seven of these doses over three and one half days prior to arrival at the emergency department. The patient received 40 mg of digoxin immune Fab fragments over one hour to bind a calculated maximum digoxin dose of 600 micrograms. The only complication was a transient episode of relative hypoglycemia 13 to 22 hours postinfusion with measured glucose readings between 43 and 52 mg/dl. The hypoglycemia responded to supplemental glucose and advancement of feedings. We believe that in massive and rapid electrolyte shifts in the neonate caused by digoxin immune Fab, glucose should be monitored closely.
我们报告了在一名7日龄男婴中使用地高辛免疫Fab治疗地高辛中毒的情况。该患者因阵发性室上性心动过速(PSVT)正在接受地高辛治疗。处方开具的是地高辛酏剂(50微克/毫升),每日两次,每次10微克;然而,配发的剂量却是每日两次,每次100微克。在抵达急诊科之前的三天半时间里,该患者共接受了七剂这样的药物。患者在一小时内接受了40毫克地高辛免疫Fab片段,以结合计算得出的最大600微克地高辛剂量。唯一的并发症是输注后13至22小时出现短暂的相对性低血糖,测得的血糖读数在43至52毫克/分升之间。低血糖通过补充葡萄糖和增加喂养量得到缓解。我们认为,由于地高辛免疫Fab导致新生儿出现大量快速的电解质转移,应密切监测血糖。